Cavanagh Bethany J
SEC CIK 2033155 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BEAM | Beam Therapeutics Inc. | SVP, Fin, Treas | 51.2K | — | $709.2K | 11 | 2024-09-30 | 2026-04-01 |
Most active insiders at BEAM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FMR LLC | 10%, See Remark 1 | — | $10.05M |
| 2 | Evans John M. | CEO, Dir | — | $6.28M |
| 3 | Ciaramella Giuseppe | Pres | — | $1.41M |
| 4 | Bellon Christine | CLO | — | $881.0K |
| 5 | Simon Amy | Chief Medical Off | — | $606.7K |
| 6 | Cavanagh Bethany J | SVP, Fin, Treas | — | $399.5K |
| 7 | Emany Sravan Kumar | CFO | — | $170.6K |
Transactions 11
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-04-06 17:39 | 2026-04-01 | BEAM | Beam Therapeutics Inc. | Cavanagh Bethany J | SVP, Fin, Treas | S - Sale | $24.58 | -3,242 | 51.2K | -6% | -$79.7K |
| 2026-04-02 17:22 | 2026-03-31 | BEAM | Beam Therapeutics Inc. | Cavanagh Bethany J | SVP, Fin, Treas | A - Grant | $0.00 | +20.0K | 54.8K | +57% | $0 | |
| T | 2026-01-26 | 2026-01-22 | BEAM | Beam Therapeutics Inc. | Cavanagh Bethany J | SVP, Fin, Treas | S - Sale | $35.00 | -6,198 | 34.8K | -15% | -$216.9K |
| T | 2026-01-21 | 2026-01-20 | BEAM | Beam Therapeutics Inc. | Cavanagh Bethany J | SVP, Fin, Treas | S - Sale | $30.12 | -3,034 | 41.0K | -7% | -$91.4K |
| T | 2025-10-03 | 2025-10-01 | BEAM | Beam Therapeutics Inc. | Cavanagh Bethany J | SVP, Fin, Treas | S - Sale | $24.53 | -467 | 44.0K | -1% | -$11.5K |
| T | 2025-04-03 | 2025-04-01 | BEAM | Beam Therapeutics Inc. | Cavanagh Bethany J | SVP, Fin, Treas | S - Sale | $18.35 | -3,015 | 44.5K | -6% | -$55.3K |
| 2025-04-02 | 2025-03-31 | BEAM | Beam Therapeutics Inc. | Cavanagh Bethany J | SVP, Fin, Treas | A - Grant | $0.00 | +10.0K | 47.5K | +27% | $0 | |
| T | 2025-02-20 | 2025-02-18 | BEAM | Beam Therapeutics Inc. | Cavanagh Bethany J | SVP, Fin, Treas | S - Sale | $35.00 | -6,287 | 37.5K | -14% | -$220.0K |
| T | 2025-01-06 | 2025-01-02 | BEAM | Beam Therapeutics Inc. | Cavanagh Bethany J | SVP, Fin, Treas | S - Sale | $24.68 | -1,117 | 43.8K | -2% | -$27.6K |
| T | 2024-10-02 | 2024-09-30 | BEAM | Beam Therapeutics Inc. | Cavanagh Bethany J | SVP, Fin, Treas | A - Grant | $0.00 | +2,500 | 45.2K | +6% | $0 |
| T | 2024-10-02 | 2024-10-01 | BEAM | Beam Therapeutics Inc. | Cavanagh Bethany J | SVP, Fin, Treas | S - Sale | $23.48 | -289 | 44.9K | -0.6% | -$6,786 |
Purchase Sale Sale after option exercise All abbreviations